PL4385509T3 - Schemat dawkowania migalastatu o ulepszonej farmakokinetyce - Google Patents

Schemat dawkowania migalastatu o ulepszonej farmakokinetyce

Info

Publication number
PL4385509T3
PL4385509T3 PL23176366.5T PL23176366T PL4385509T3 PL 4385509 T3 PL4385509 T3 PL 4385509T3 PL 23176366 T PL23176366 T PL 23176366T PL 4385509 T3 PL4385509 T3 PL 4385509T3
Authority
PL
Poland
Prior art keywords
dosing regimen
improved pharmacokinetics
migalastat
migalastat dosing
pharmacokinetics
Prior art date
Application number
PL23176366.5T
Other languages
English (en)
Polish (pl)
Inventor
Franklin Johnson
Original Assignee
Amicus Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amicus Therapeutics, Inc. filed Critical Amicus Therapeutics, Inc.
Publication of PL4385509T3 publication Critical patent/PL4385509T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL23176366.5T 2022-12-13 2023-05-31 Schemat dawkowania migalastatu o ulepszonej farmakokinetyce PL4385509T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263432235P 2022-12-13 2022-12-13
US18/315,928 US20240197706A1 (en) 2022-12-13 2023-05-11 Methods of improving the pharmacokinetics of migalastat

Publications (1)

Publication Number Publication Date
PL4385509T3 true PL4385509T3 (pl) 2026-02-16

Family

ID=86646511

Family Applications (1)

Application Number Title Priority Date Filing Date
PL23176366.5T PL4385509T3 (pl) 2022-12-13 2023-05-31 Schemat dawkowania migalastatu o ulepszonej farmakokinetyce

Country Status (23)

Country Link
US (1) US20240197706A1 (https=)
EP (2) EP4385509B1 (https=)
JP (2) JP7757345B2 (https=)
KR (1) KR20240094973A (https=)
AU (1) AU2023396459A1 (https=)
CA (1) CA3201512A1 (https=)
CL (1) CL2025001743A1 (https=)
CO (1) CO2025009079A2 (https=)
DE (1) DE202023003007U1 (https=)
DK (1) DK4385509T3 (https=)
ES (1) ES3055214T3 (https=)
FI (1) FI4385509T3 (https=)
HR (1) HRP20251472T1 (https=)
IL (1) IL321404A (https=)
LT (1) LT4385509T (https=)
MX (1) MX2025006897A (https=)
PL (1) PL4385509T3 (https=)
PT (1) PT4385509T (https=)
RS (1) RS67478B1 (https=)
SI (1) SI4385509T1 (https=)
SM (1) SMT202500453T1 (https=)
TW (1) TW202423436A (https=)
WO (1) WO2024129220A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274597B1 (en) 1998-06-01 2001-08-14 Mount Sinai School Of Medicine Of New York University Method of enhancing lysosomal α-Galactosidase A
MX2009010557A (es) 2007-03-30 2009-11-19 Amicus Therapeutics Inc Metodo para el tratamiento de la enfermedad de fabry que utiliza chaperonas farmacologicas.
US9999618B2 (en) * 2007-04-26 2018-06-19 Amicus Therapeutics, Inc. Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones
EP2946785B1 (en) 2008-02-12 2018-10-24 Amicus Therapeutics, Inc. Method to predict response to pharmacological chaperone treatment of diseases
SG10201604757RA (en) * 2011-03-11 2016-08-30 Amicus Therapeutics Inc Dosing regimens for the treatment of fabry disease
EP4426846A4 (en) * 2021-11-03 2025-11-05 Sangamo Therapeutics Inc METHODS OF USING VIRAL VECTOR CONSTRUCTIONS FOR THE TREATMENT OF FABRY DISEASE

Also Published As

Publication number Publication date
TW202423436A (zh) 2024-06-16
US20240197706A1 (en) 2024-06-20
AU2023396459A1 (en) 2025-06-26
JP2026031546A (ja) 2026-02-24
JP2024084670A (ja) 2024-06-25
RS67478B1 (sr) 2025-12-31
SMT202500453T1 (it) 2026-01-12
EP4667050A3 (en) 2026-03-25
WO2024129220A1 (en) 2024-06-20
EP4385509A1 (en) 2024-06-19
IL321404A (en) 2025-08-01
FI4385509T3 (fi) 2025-12-05
CO2025009079A2 (es) 2025-09-29
HRP20251472T1 (hr) 2026-01-02
PT4385509T (pt) 2025-11-25
CL2025001743A1 (es) 2025-10-03
DE202023003007U1 (de) 2025-07-21
JP7757345B2 (ja) 2025-10-21
SI4385509T1 (sl) 2026-01-30
MX2025006897A (es) 2025-07-01
KR20240094973A (ko) 2024-06-25
CA3201512A1 (en) 2024-06-13
ES3055214T3 (en) 2026-02-10
DK4385509T3 (da) 2025-12-08
EP4385509B1 (en) 2025-09-03
LT4385509T (lt) 2025-12-29
EP4667050A2 (en) 2025-12-24

Similar Documents

Publication Publication Date Title
EP3852609C0 (en) ELECTRODE PATCH WITH MULTIPLE MEASURING POINTS
IL279427A (en) Sensors having an active surface
EP3980739A4 (en) DEFORMABLE SENSORS WITH SELECTIVE MOUNTING
EP4265852A4 (en) CONSTRUCTION EQUIPMENT
EP3838065C0 (en) HAIRBRUSH WITH INLET BRISTLES
EP4457566A4 (en) PHOTOCURABLE COMPOSITION WITH IMPROVED THERMAL STABILITY
DK3986920T3 (da) Tnfr2-agonister med forbedret stabilitet
EP4098806A4 (en) Construction machine
EP3947221A4 (en) A pallet stacker
DK3766825T3 (da) Teleskoplæsser med stabilisatorer
EP4234819A4 (en) CONSTRUCTION EQUIPMENT
EP4227160A4 (en) CONSTRUCTION EQUIPMENT
PL3822524T3 (pl) Czujnik zderzeniowy z wahadłem
EP3824125C0 (en) KNITTED TEXTILES HAVING ENHANCED MOISTURE TRANSPORT PROPERTIES
JP1718804S (ja) 収納付きアクセサリー
PL4385509T3 (pl) Schemat dawkowania migalastatu o ulepszonej farmakokinetyce
EP4410331A4 (en) SYRINGE
EP4326239A4 (en) EXTRACELLULAR VESICLES LOADED WITH BIOMOLECULES
EP4458076A4 (en) ENHANCED REDUCED CAPACITY USER EQUIPMENT
EP3836993C0 (en) FIXED DOSE INJECTION PENS
EP4028715C0 (de) Unterwasserfahrzeug mit zwei hintereinander angeordneten hohlladungen
EP4426492A4 (en) SENSOR WITH AN ACTIVE SURFACE
PL3835250T3 (pl) Maszyna robocza z ulepszonymi stabilizatorami
ES1270264Y (es) Boquilla dosificadora
DE112022001193A5 (de) Messanordnung